Skip to main content
SpringerLink
Log in
Book cover

Turning up the Heat on Pain: TRPV1 Receptors in Pain and Inflammation pp 211–225Cite as

TRPV1 agonist therapies in bladder diseases

  • Chapter

Part of the book series: Progress in Inflammation Research ((PIR))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. de Groat WC (1997) A neurologic basis for the overactive bladder. Urology 50(Suppl 6A): 36–52

    PubMed  Google Scholar 

  2. Yokoyama O, Nagano K, Kawaguchi K, Ueki O, Mitsuo O (1994) The influence of prostatic urethral anesthesia in overactive detrusor in patients with benign prostatic hyperplasia. J Urol 151: 1554–1556

    PubMed  CAS  Google Scholar 

  3. Chai TC, Gray ML, Steers W (1998) The incidence of a positive ice water test in bladder outlet obstructed patients: evidence for bladder neural plasticity. J Urol 160: 34–38

    PubMed  CAS  Google Scholar 

  4. Smet PJ, Moore KH, Jonavicius J (1997) Distribution and colocalization of calcitonin gene-related peptide tachykinins and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab Invest 77: 37–49

    PubMed  CAS  Google Scholar 

  5. Steers WD, de Groat WC (1988) Effect of bladder outlet obstruction on micturition reflex pathways in the rat. J Urol 140: 864–871

    PubMed  CAS  Google Scholar 

  6. Cruz F, Avelino A, Coimbra A (1996) Desensitization follows excitation of bladder primary afferents by intravesical capsaicin, as shown by c-fos activation in the rat spinal cord. Pain 64: 553–557

    Article  PubMed  CAS  Google Scholar 

  7. Avelino A, Cruz F, Coimbra A (1999) Intravesical resiniferatoxin desensitizes rat bladder sensory fibres without causing intense noxious excitation. A c-fos study. Eur J Pharmacol 378: 17–22

    Article  PubMed  CAS  Google Scholar 

  8. Avelino A, Cruz F (2000) Peptide immunoreactivity and ultrastructure of rat urinary bladder nerve fibers after topical desensitization by capsaicin or resiniferatoxin. Auton Neurosci 86: 37–46

    PubMed  CAS  Google Scholar 

  9. Chapple CR (2000) Muscarinic receptor antagonists in the treatment of overactive bladder. Urology 55(Suppl 5A): 33–46

    PubMed  CAS  Google Scholar 

  10. Fowler CJ, Jewkes D, McDonald WI, Lynn B, de Groat WC (1992) Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 339: 1239

    PubMed  CAS  Google Scholar 

  11. Fowler CJ, Beck RO, Gerrard S, Betts CD, Fowler CG (1994) Intravesical capsaicin for the treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry 57: 169–173

    PubMed  CAS  Google Scholar 

  12. Geirsson G, Fall M, Sullivan L (1995) Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperreflexia. J Urol 154: 1825–1829

    PubMed  CAS  Google Scholar 

  13. Das A, Chancellor MB, Watanabe T, Sedor J, Rivas DA (1996) Intravesical capsaicin in neurogenic impaired patients with detrusor hyperreflexia. J Spinal Cord Med 19: 190–193

    PubMed  CAS  Google Scholar 

  14. Igawa Y, Komiyama I, Nishizawa O, Ogawa A (1996) Intravesical capsaicin inhibits autonomic dysreflexia in patients with spinal cord injury. Neurourol Urodyn 15: 374–375

    Google Scholar 

  15. Cruz F, Guimarães M, Silva C, Rio ME, Coimbra A, Reis M (1997) Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction. J Urol 157: 585–589

    PubMed  CAS  Google Scholar 

  16. De Ridder D, Chandiramani V, Dasgupta P, Van Poppel H, Baert L, Fowler CJ (1997) Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup. J Urol 158: 2087–2092

    PubMed  Google Scholar 

  17. de Séze M, Wiart L, Joseph PA, Dosque JP, Mazaux JM, Barat M (1998) Capsaicin and neurogenic detrusor hyperreflexia. A double blind placebo controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn 17: 513–523

    PubMed  Google Scholar 

  18. Cruz F, Guimarães M, Silva C, Reis M (1997) Supression of bladder hyperreflexia by intravesical resiniferatoxin. Lancet 350: 640–641

    Article  PubMed  CAS  Google Scholar 

  19. Lazzeri M, Beneforti P, Turini D (1997) Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor. J Urol 158: 2093–2096

    PubMed  CAS  Google Scholar 

  20. Lazzeri M, Spinelli M, Beneforti P, Zanollo A, Turini D (1998) Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases. Scand J Urol Nephrol 32: 331–334

    PubMed  CAS  Google Scholar 

  21. Silva C, Rio ME, Cruz F (2000) Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia. Eur Urol 38: 444–452

    Article  PubMed  CAS  Google Scholar 

  22. Brady CM, Apostolidis AN, Harper M, Yiangou Y, Beckett A, Jacques TS, Freeman A, Scaravilli F, Fowler CJ, Anand P (2004) Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment. BJU Int 93: 770–776

    Article  PubMed  CAS  Google Scholar 

  23. Cruz F, Silva C, Ribeiro M, Avelino A (2002) The effect of intravesical resiniferatoxin in neurogenic forms of bladder overactivity. Preliminary results of a randomised placebo controlled clinical trial. Neurourol Urodyn 21: 426–427

    Google Scholar 

  24. Park WH, Kim HG, Park BJ, Kim DY, Oh DJ, Lim YS, Shim HB (1999) Comparison of the effects of intravesical capsaicin and resiniferatoxin for treatment of detrusor hyperreflexia in patients with spinal cord injury. Neurourol Urodyn 18: 402

    Google Scholar 

  25. Giannantoni A, Di Stasi SM, Stephen RL, Navarra P, Scivoletto G, Mearini E, Porena M (2002) Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. J Urol 167: 1710–1714

    PubMed  CAS  Google Scholar 

  26. de Seze M, Wiart L, de Seze MP, Soyeur L, Dosque JP, Blajezewski S, Moore N, Brochet B, Mazaux JM, Barat M, Joseph PA (2004) Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a doubleblind, randomized, controlled study. J Urol 171: 251–255

    PubMed  Google Scholar 

  27. Peters TJ, Donovan JL, Kay HE, Abrams P, de la Rosette JJMCH, Porru D, Thuroff JW (1997) The International Continence Society “Benign Prostatic Hyperplasia” study: the bothersomeness of urinary symptoms. J Urol 157: 885–889

    PubMed  CAS  Google Scholar 

  28. Dinis P, Silva J, Ribeiro MJ, Avelino A, Reis M, Cruz F (2004) Bladder C-fiber desensitization induces a long-lasting improvement of BPH-associated storage LUTS. A pilot study. Eur Urol 46: 88–93; discussion 93-94

    Article  PubMed  Google Scholar 

  29. Kuo H (2003) Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions. J Urol 170: 835–839

    PubMed  Google Scholar 

  30. Debruyne FJM, Heesakkers JPFA, (2004) Clinical and socioeconomic relevance of overactive bladder. Urology 63(3A): 42–44

    PubMed  Google Scholar 

  31. Silva C, Ribeiro MJ, Cruz F (2002) The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol 168: 575–579

    PubMed  CAS  Google Scholar 

  32. Palma P, Dambros M, Thiel M, Fraga R, Riccetto CLZ, Netto NR (2003) Resultados preliminares da resiniferatoxina no tratamento de pacientes com instabilidade detrusora. Urodinamica Aplicada 16: 261–267

    Google Scholar 

  33. Szallasi A, Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51: 159–211

    PubMed  CAS  Google Scholar 

  34. Avelino A, Cruz C, Nagy I, Cruz F, (2002) Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 109: 787–798

    Article  PubMed  CAS  Google Scholar 

  35. Brady C, Apostolidis AN, Yiangou Y, Baecker PA, Ford AP, Fowler CJ, Anand P (2003) P2X3-immunoreactive nerve fibers in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin (RTX). Eur Urol 2(Suppl): 93 (abstract)

    Google Scholar 

  36. Avelino A, Cruz C, Cruz F (2002) Nerve growth factor regulates galanin and c-jun overexpression occurring in dorsal root ganglion cells after intravesical resiniferatoxin application. Brain Res 951: 264–269

    Article  PubMed  CAS  Google Scholar 

  37. Miller MS, Buck SH, Sipes IG, Yamamura HI, Burks TF (1982) Regulation of substance P by nerve growth factor: disruption by capsaicin. Brain Res 250: 193–196

    Article  PubMed  CAS  Google Scholar 

  38. Taylor DCM, Pierau FK, Szolcsányi J (1984) Long lasting inhibition of horseradish peroxidase (HRP) transport in sensory nerves induced by capsaicin treatment of the receptive field. Brain Res 298: 45–49

    Article  PubMed  CAS  Google Scholar 

  39. Vizzard MA (2000) Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol 161: 273–284

    Article  PubMed  CAS  Google Scholar 

  40. Seki S, Sasaki K, Fraser MO, Igawa Y, Nishizawa O, Chancellor MB, de Groat WC, Yoshimura N (2002) Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats. J Urol 168: 2269–2274

    PubMed  CAS  Google Scholar 

  41. Steers WD, Kolbeck S, Creedon D, Tuttle JB (1991) Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest 88: 1709–1715

    Article  PubMed  CAS  Google Scholar 

  42. Chuang YC, Fraser MO, Yu Y, Chancellor MB, de Groat WC, Yoshimura N (2001) The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor. J Urol 165: 975–979

    PubMed  CAS  Google Scholar 

  43. Steers WD, Creedon DJ, Tuttle JB (1996) Immunity to nerve growth factor prevents afferent plasticity following urinary bladder hypertrophy. J Urol 155: 379–385

    PubMed  CAS  Google Scholar 

  44. Dasgupta P, Chandiramani V, Parkinson MC, Beckett A, Fowler CJ (1998) Treating the human bladder with capsaicin: is it safe? Eur Urol 33: 28–31

    Article  PubMed  CAS  Google Scholar 

  45. Silva C, Avelino A, Souto-Moura C, Cruz F (2001) A light and electron microscope histopathological study of the human bladder mucosa after intravesical resiniferatoxin application. BJU Int 88: 355–360

    Article  PubMed  CAS  Google Scholar 

  46. Dinis P, Charrua A, Avelino A, Cruz F (2004) Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladders. BJU Int 94: 153–157

    Article  PubMed  Google Scholar 

  47. Maggi CA, Barbanti G, Santicioli P, Beneforti P, Misuri D, Meli A, Turini D (1989) Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans. J Urol 142: 150–154

    PubMed  CAS  Google Scholar 

  48. Barbanti G, Maggi CA, Beneforti P, Baroldi P, Turini D (1993) Relief of pain following intravesical capsaicin in patients with hypersensitive disorders of the lower urinary tract. BJU 71: 686–691

    Article  PubMed  CAS  Google Scholar 

  49. Lazzeri M, Beneforti P, Benaim G, Maggi CA, Lecci A, Turini D (1996) Intravesical capsaicin for treatment of severe bladder pain: a randomized placebo controlled study. J Urol 156: 947–952

    PubMed  CAS  Google Scholar 

  50. Lazzeri M, Beneforti P, Spinelli M, Zanollo A, Barbagli G, Turini D (2000) Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study. J Urol 164: 676–679

    PubMed  CAS  Google Scholar 

  51. Lazzeri M, Spinelli M, Beneforti P, Malaguti S, Giardiello G, Turini D (2004) Intravesical infusion of resiniferatoxin by a temporary in situ drug delivery system to treat interstitial cystitis: a pilot study. Eur Urol 45: 98–102

    Article  PubMed  CAS  Google Scholar 

  52. Guo A, Vulchanova L, Wang J, Li X, Elde R (1999) Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoreceptor and IB4 binding sites. Eur J Neurosci 11: 946–958

    Article  PubMed  CAS  Google Scholar 

  53. Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L et al (2000) Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407: 1011–1015

    Article  PubMed  CAS  Google Scholar 

  54. Birder LA, Nakamura Y, Kiss S, Nealen ML, Barrick S, Kanai AJ, Wang E, Ruiz G, De Groat WC, Apodaca G et al (2002) Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 5: 856–860

    Article  PubMed  CAS  Google Scholar 

  55. Avelino A, Dinis P, Charrua A., Nagy I, Yacoob M, Cruz F (2003) The endogenous TRPV1 ligand anandamide increases in the rat inflamed urinary bladder and may contribute to inflammatory pain. Program 608.3. Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington DC

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department or Urology, Hospital S. João and Faculty of Medicine of Porto, 4200-076, Porto, Portugal

    Francisco Cruz, Carlos Silva & Paulo Dinis

Authors
  1. Francisco Cruz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paulo Dinis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Elan Pharmaceuticals, 800 Gateway Boulevard, South San Francisco, CA, 94080, USA

    Annika B. Malmberg

  2. NeurogesX, Inc., 981F Industrial Road, San Carlos, CA, 94070, USA

    Keith R. Bley

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Cruz, F., Silva, C., Dinis, P. (2005). TRPV1 agonist therapies in bladder diseases. In: Malmberg, A.B., Bley, K.R. (eds) Turning up the Heat on Pain: TRPV1 Receptors in Pain and Inflammation. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7379-2_11

Download citation

  • DOI: https://doi.org/10.1007/3-7643-7379-2_11

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-7643-7080-0

  • Online ISBN: 978-3-7643-7379-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation